HALEOSLABS Quarterly Results, Profit & Loss, Balance Sheet (HALEOSLABS)

HALEOSLABS quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.

Haleos Labs Ltd (HALEOSLABS) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow

Haleos Labs Ltd reported sales of ₹72.94 Cr, operating profit of ₹9.12 Cr (OPM 12.5%) and net profit of ₹1.84 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.

HALEOSLABS quarterly results (₹ Cr)
MetricSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales78.4684.689.1182.581.3794.7875.1472.94
Expenses69.8971.8581.6970.7967.7980.7370.9863.82
Operating Profit8.5712.757.4211.7113.5814.054.169.12
OPM10.92%15.07%8.33%14.19%16.69%14.82%5.54%12.5%
Other Income2.040.062.3410.420.182.010.46
Interest2.142.142.031.871.621.541.421.9
Depreciation3.763.763.83.823.893.913.854.24
Profit before tax4.716.913.937.028.498.780.93.44
Tax29.72%29.81%11.45%37.61%24.38%24.26%62.22%46.51%
Net Profit3.34.863.484.396.426.650.351.84
EPS in Rs15.4518.099.8213.7620.1821.91.468.77
HALEOSLABS profit & loss, annual (₹ Cr)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales350316306345334324
Expenses316287275300289283
Operating Profit352931454541
OPM10%9%10%13%13%13%
Other Income1454523
Interest6710966
Depreciation101115151516
Profit before tax331710262522
Tax23%31%36%28%29%-
Net Profit25116191815
EPS in Rs83.7537.9130.0766.5257.2652.31
Dividend Payout2%4%5%2%3%-
HALEOSLABS balance sheet (₹ Cr)
MetricMar 2023Mar 2024Mar 2025Sep 2025Mar 2026
Equity Capital33333
Reserves166174194203211
Borrowings1001018670111
Other Liabilities126114107118130
Total Liabilities395391390394454
Fixed Assets228223232226268
CWIP160910
Investments00000
Other Assets166162158159176
Total Assets395391390394454
HALEOSLABS cash flows (₹ Cr)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity-1115243437
Cash from Investing Activity-7-31-18-15-58
Cash from Financing Activity1117-7-1921
Net Cash Flow-80-101
Free Cash Flow-53-28419-21
CFO/OP-10%62%88%94%98%
HALEOSLABS ratios
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days3553617367
Inventory Days159184196160210
Days Payable146127143126162
Cash Conversion Cycle48110115106116
Working Capital Days17241175
ROCE12%8%7%12%10%